Amanote Research
Register
Sign In
Discovery of Potent and Orally Available Malonyl-CoA Decarboxylase Inhibitors as Cardioprotective Agents
doi 10.1021/jm0605029.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Peroxisomal-Proliferator-Activated Receptor Alpha Activates Transcription of the Rat Hepatic Malonyl-CoA Decarboxylase Gene: A Key Regulation of Malonyl-CoA Level
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Malonyl-CoA Decarboxylase Inhibition Is Selectively Cytotoxic to Human Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimers Agents by Structure-Based Design
Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lymphocyte-Specific Kinase: Synthesis, Structure-Activity Relationship, and in Vivo Anti-Inflammatory Activity
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A
Discovery of Inhibitors of Aurora/PLK Targets as Anticancer Agents
2-(S)-Phenethylaminothiazolones as Potent, Orally Efficacious Inhibitors of 11b-Hydroxysteriod Dehydrogenase Type 1
Exploration of Orally Available Calpain Inhibitors 2: Peptidyl Hemiacetal Derivatives
